The Investor's Almanac

SpaceX IPO: Why One Analyst Says Avoid the Offering

satellite dish antenna - Large satellite dish against a blue sky

Photo by Bernd 📷 Dittrich on Unsplash

Photo by SpaceX on Unsplash

The Number That Frames the Whole Debate

More than $150 billion. As of September 21, 2026, that is the level SpaceX shares have changed hands at in recent private tender offers, according to the research underpinning Fortune's coverage — and it is the number every argument about a SpaceX IPO eventually collides with.

According to Google News, which distributed the Fortune report, a top analyst has issued a blunt call on the prospect of a SpaceX public offering: "We recommend that investors avoid this IPO." That is the quote, attributed to the analyst in Fortune's reporting. It is unusually direct language for a company that does not currently have a ticker, a filing, or a confirmed date.

Our thesis, stated so it can be proven wrong: the analyst's "avoid" is not really a verdict on SpaceX the business — it is a verdict on the price a retail investor would be handed on day one, and on the fact that the company has given public markets almost nothing to underwrite with.

The Evidence: What Is Actually Public

Start with what can be verified. SpaceX has raised private capital at valuations exceeding $100 billion in recent years, and recent tender offers — the mechanism that lets employees sell existing shares to selected investors — have cleared above $150 billion. Both figures are disclosed marks, not estimates.

Line those two disclosed marks up next to each other and the arithmetic is simple: the tender-offer level sits roughly 1.5 times the earlier round level. That is not a growth rate, and it should not be read as one — the two marks come from different mechanisms at different times. But it is the only price series ordinary investors have, and a 1.5x step-up between the two disclosed reference points is the entire basis on which "SpaceX is cheap" or "SpaceX is expensive" gets argued.

over $100B over $150B Private funding rounds Recent tender offers Disclosed reference points, not an audited valuation series

Chart: The two disclosed SpaceX valuation reference points cited in reporting as of September 21, 2026. Neither is an audited public-market price.

On the revenue side, the picture is qualitatively strong and quantitatively opaque. SpaceX generates significant revenue from two very different engines: Starlink satellite internet, a recurring-subscription consumer and enterprise business, and NASA contracts, a lumpy, procurement-driven government business. Those two lines have almost nothing in common as investments. One is a subscriber-growth story with churn, capex intensity, and a hardware supply chain. The other is a contract-backlog story whose cadence is set by federal appropriations.

That mix is the part surface coverage keeps flattening. A subscription business and a government-contract business do not deserve the same multiple, and no investor outside the private rounds currently has the segment disclosure to weight them. You cannot run a credible discounted-cash-flow model on a company that has not told you what fraction of revenue renews every month.

Where a Careful Skeptic Pushes Back

The bear case deserves better than a paragraph, but so does the bull case — and the bull case here is genuinely serious.

The strongest rebuttal to "avoid this IPO" is that the analyst is rating a security that does not exist. As of early 2025, per the research record, SpaceX had not officially announced IPO plans. Elon Musk has historically said he does not intend to take SpaceX public until Mars missions are running on a regular basis. So the recommendation is being issued against a hypothetical: unknown float size, unknown lockup terms, unknown offer price, unknown segment disclosure. A rating without an S-1 is a rating on a rumor.

There is a second, sharper pushback. Tender-offer prices are not market prices. They are negotiated between a company and a curated set of buyers, with no short sellers, no forced sellers, and no daily mark. Whether that produces a number that is too high or too low is genuinely unknowable from the outside — which cuts against both the analyst's caution and the enthusiasts' "we finally get access" framing.

And there is a divergence worth naming honestly: at the time of writing, the "avoid" verdict traces to a single outlet, Fortune. Sector analysis built on one source and one unnamed analyst is a starting point for investment research, not a conclusion. The absence of corroborating coverage from other financial outlets is itself a data point — it suggests this is one house's view, not a consensus turn in market trends. The same dynamic shows up in private-company financing generally, a pattern explored in Startup Lens's look at where Series A rounds actually price: the headline valuation and the realizable valuation are rarely the same number.

The Starlink Wrinkle

One detail changes the shape of the question entirely. Musk has publicly floated Starlink as a separate IPO candidate. If the satellite internet division lists on its own, public investors get the recurring-revenue half of the business without the launch-services and Mars-program half — a cleaner asset to value, and a very different security than "SpaceX." An "avoid the SpaceX IPO" call does not automatically extend to a Starlink-only listing.

The Watchlist

There is nothing to trade here, which is precisely why a watchlist beats a reaction. Four things are worth tracking rather than guessing at:

1. An actual S-1 filing.

Until a registration statement exists, segment revenue for Starlink versus NASA contracts, capex on the satellite supply chain, and share-class structure are all unknown. No stock analysis is possible without them. Track the SEC EDGAR full-text search rather than headlines.

2. The next tender offer level.

Each new tender gives one more disclosed price point. Whether the next one clears above, at, or below the $150 billion-plus mark is the single most informative signal available to outsiders right now.

3. Which entity files first.

Starlink alone versus consolidated SpaceX are materially different offerings. Investors are watching the entity name on any filing at least as closely as the valuation.

4. Whether a second analyst corroborates.

One "avoid" is an opinion. Three independent "avoids" with published valuation work is a signal. Data suggests waiting for the second and third before treating this as sector consensus.

Frequently Asked Questions

Is SpaceX going public in 2026?

No IPO has been officially announced. Per the research record, SpaceX had not announced IPO plans as of early 2025, and Musk has historically said he does not plan to take the company public until Mars missions are regular. Any 2026 timeline circulating publicly is speculation unless a filing appears.

How can retail investors buy SpaceX stock before an IPO?

Broad retail access does not currently exist. SpaceX conducts private tender offers that let employees sell shares to select investors — a channel limited to qualifying participants, not the general public. Vehicles marketed as offering pre-IPO exposure carry their own fee and structure risks worth reading closely.

Why would an analyst recommend avoiding the SpaceX IPO?

The stated verdict in Fortune's reporting is the quote itself; the reasoning most commonly raised in coverage centers on valuation levels reached in private markets and the timing of any offering given the company's long-horizon Mars program. A skeptic's counterpoint is that no offer price, float, or disclosure package yet exists to rate.

Bottom Line

Our read: the more useful takeaway is not "avoid" or "buy," but that a valuation above $150 billion set in curated private transactions is a fragile anchor for a public offering, and that a company blending a subscription business with a government-contract business owes investors segment disclosure before any of this is analyzable. On balance, the honest position as of September 21, 2026 is that there is not yet enough public information to form a view — and anyone selling certainty on a SpaceX IPO is selling something other than research.

Disclaimer: This article is editorial commentary for educational and informational purposes only. It does not constitute financial advice, a recommendation, or an endorsement of any security, and it does not reflect independent product testing. Always do your own research and consult a licensed financial advisor before making investment decisions. Research based on publicly available sources current as of September 21, 2026.